Global Platinum based Cancer Drug Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 113

Report ID: 5285

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Asia-Pacific is the largest market, with a sales market share nearly 53% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
The global Platinum based Cancer Drug market is valued at 1290 million US$ in 2018 and will reach 1740 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Platinum based Cancer Drug market based on company, product type, end user and key regions.

This report studies the global market size of Platinum based Cancer Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Platinum based Cancer Drug in these regions.
This research report categorizes the global Platinum based Cancer Drug market by top players/brands, region, type and end user. This report also studies the global Platinum based Cancer Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Market size by Product
Cisplatin
Oxaliplatin
Carboplatin
Other
Market size by End User
Colorectal Cancer
Ovarian Cancer
Lung Cancer 
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Platinum based Cancer Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Platinum based Cancer Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Platinum based Cancer Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Platinum based Cancer Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Platinum based Cancer Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Platinum based Cancer Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Platinum based Cancer Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Product
1.4.2 Cisplatin
1.4.3 Oxaliplatin
1.4.4 Carboplatin
1.4.5 Other
1.5 Market by End User
1.5.1 Global Platinum based Cancer Drug Market Size Growth Rate by End User
1.5.2 Colorectal Cancer
1.5.3 Ovarian Cancer
1.5.4 Lung Cancer 
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Platinum based Cancer Drug Market Size
2.1.1 Global Platinum based Cancer Drug Revenue 2014-2025
2.1.2 Global Platinum based Cancer Drug Sales 2014-2025
2.2 Platinum based Cancer Drug Growth Rate by Regions
2.2.1 Global Platinum based Cancer Drug Sales by Regions
2.2.2 Global Platinum based Cancer Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Platinum based Cancer Drug Sales by Manufacturers
3.1.1 Platinum based Cancer Drug Sales by Manufacturers
3.1.2 Platinum based Cancer Drug Sales Market Share by Manufacturers
3.1.3 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI)
3.2 Platinum based Cancer Drug Revenue by Manufacturers
3.2.1 Platinum based Cancer Drug Revenue by Manufacturers (2014-2019)
3.2.2 Platinum based Cancer Drug Revenue Share by Manufacturers (2014-2019)
3.3 Platinum based Cancer Drug Price by Manufacturers
3.4 Platinum based Cancer Drug Manufacturing Base Distribution, Product Types
3.4.1 Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Platinum based Cancer Drug Product Type
3.4.3 Date of International Manufacturers Enter into Platinum based Cancer Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Platinum based Cancer Drug Sales by Product
4.2 Global Platinum based Cancer Drug Revenue by Product
4.3 Platinum based Cancer Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Platinum based Cancer Drug Breakdown Data by End User

6 North America
6.1 North America Platinum based Cancer Drug by Countries
6.1.1 North America Platinum based Cancer Drug Sales by Countries
6.1.2 North America Platinum based Cancer Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Platinum based Cancer Drug by Product
6.3 North America Platinum based Cancer Drug by End User

7 Europe
7.1 Europe Platinum based Cancer Drug by Countries
7.1.1 Europe Platinum based Cancer Drug Sales by Countries
7.1.2 Europe Platinum based Cancer Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Platinum based Cancer Drug by Product
7.3 Europe Platinum based Cancer Drug by End User

8 Asia Pacific
8.1 Asia Pacific Platinum based Cancer Drug by Countries
8.1.1 Asia Pacific Platinum based Cancer Drug Sales by Countries
8.1.2 Asia Pacific Platinum based Cancer Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Platinum based Cancer Drug by Product
8.3 Asia Pacific Platinum based Cancer Drug by End User

9 Central & South America
9.1 Central & South America Platinum based Cancer Drug by Countries
9.1.1 Central & South America Platinum based Cancer Drug Sales by Countries
9.1.2 Central & South America Platinum based Cancer Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Platinum based Cancer Drug by Product
9.3 Central & South America Platinum based Cancer Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Platinum based Cancer Drug by Countries
10.1.1 Middle East and Africa Platinum based Cancer Drug Sales by Countries
10.1.2 Middle East and Africa Platinum based Cancer Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Platinum based Cancer Drug by Product
10.3 Middle East and Africa Platinum based Cancer Drug by End User

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Platinum based Cancer Drug Products Offered
11.1.5 Sanofi Recent Development
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Details
11.2.2 Company Business Overview
11.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Hengrui Medicine Platinum based Cancer Drug Products Offered
11.2.5 Hengrui Medicine Recent Development
11.3 ASK Pharma
11.3.1 ASK Pharma Company Details
11.3.2 Company Business Overview
11.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 ASK Pharma Platinum based Cancer Drug Products Offered
11.3.5 ASK Pharma Recent Development
11.4 Yi Bai Pharmaceutical
11.4.1 Yi Bai Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
11.4.5 Yi Bai Pharmaceutical Recent Development
11.5 Qilu Pharmaceutical
11.5.1 Qilu Pharmaceutical Company Details
11.5.2 Company Business Overview
11.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
11.5.5 Qilu Pharmaceutical Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Company Business Overview
11.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Platinum based Cancer Drug Products Offered
11.6.5 Teva Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer Platinum based Cancer Drug Products Offered
11.7.5 Pfizer Recent Development
11.8 Dr Reddy's Laboratories
11.8.1 Dr Reddy's Laboratories Company Details
11.8.2 Company Business Overview
11.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Products Offered
11.8.5 Dr Reddy's Laboratories Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Company Business Overview
11.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Mylan Platinum based Cancer Drug Products Offered
11.9.5 Mylan Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sun Pharma Platinum based Cancer Drug Products Offered
11.10.5 Sun Pharma Recent Development
11.11 Novartis
11.12 Debiopharm
11.13 Accord Healthcare
11.14 SK Chemicals

12 Future Forecast
12.1 Platinum based Cancer Drug Market Forecast by Regions
12.1.1 Global Platinum based Cancer Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Platinum based Cancer Drug Revenue Forecast by Regions 2019-2025
12.2 Platinum based Cancer Drug Market Forecast by Product
12.2.1 Global Platinum based Cancer Drug Sales Forecast by Product 2019-2025
12.2.2 Global Platinum based Cancer Drug Revenue Forecast by Product 2019-2025
12.3 Platinum based Cancer Drug Market Forecast by End User
12.4 North America Platinum based Cancer Drug Forecast
12.5 Europe Platinum based Cancer Drug Forecast
12.6 Asia Pacific Platinum based Cancer Drug Forecast
12.7 Central & South America Platinum based Cancer Drug Forecast
12.8 Middle East and Africa Platinum based Cancer Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Platinum based Cancer Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer